换一批
换一批High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
作者：
主题词
急性病(Acute Disease);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);染色体畸变(Chromosome Aberrations);综合疗法(Combined Modality Therapy);阿糖胞苷(Cytarabine);腹泻(Diarrhea);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);血液病(Hematologic Diseases);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 髓样(Leukemia, Myeloid);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);肿瘤蛋白质类(Neoplasm Proteins);肿瘤, 继发原发性(Neoplasms, Second Primary);预后(Prognosis);复发(Recurrence);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);危险(Risk);干细胞移植(Stem Cell Transplantation);移植, 同种(Transplantation, Homologous);青年人(Young Adult);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3)
DOI
10.3109/10428194.2011.621562
PMID
21913806
发布时间
2019-12-10
- 浏览36
Leukemia & lymphoma
445-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
